ODONNELL FRANCIS E JR
SEC insider (Form 3/4/5 filer). CIK 0001066040. Chief Executive Officer at Inhibitor Therapeutics, Inc. (INTI). 1 reported Form 4/5 transaction since Sep 2024; latest on May 4, 2026. Located in TAMPA, FL.
Companies ODONNELL FRANCIS E JR has filed insider reports for
- Inhibitor Therapeutics, Inc. (INTI): Director, Officer, 10% Owner, Chief Executive Officer
ODONNELL FRANCIS E JR
CIK: 0001066040
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INTI
Inhibitor Therapeutics, Inc.
DirectorOfficer10% Owner